Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 17 November 2022 30 November 2023 30 November 2023 14490110 Lord Mark Mulvihill iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14490110 2022-11-16 14490110 2023-11-30 14490110 2022-11-17 2023-11-30 14490110 frs-core:CurrentFinancialInstruments 2023-11-30 14490110 frs-bus:PrivateLimitedCompanyLtd 2022-11-17 2023-11-30 14490110 frs-bus:FilletedAccounts 2022-11-17 2023-11-30 14490110 frs-bus:Micro-entities 2022-11-17 2023-11-30 14490110 frs-bus:AuditExempt-NoAccountantsReport 2022-11-17 2023-11-30 14490110 frs-bus:Director1 2022-11-17 2023-11-30
Registered number: 14490110
Wantsum Medical Group Limited
Unaudited Financial Statements
For the Period 17 November 2022 to 30 November 2023
Balance Sheet
Registered number: 14490110
30 November 2023
£
Fixed assets 12,449
Current assets 1,279
Creditors: Amounts Falling Due Within One Year (34,291 )
NET CURRENT LIABILITIES (33,012 )
TOTAL ASSETS LESS CURRENT LIABILITIES (20,563 )
Accruals and deferred income (299 )
NET LIABILITIES (20,862 )
CAPITAL AND RESERVES (20,862 )

Notes

1. General Information
Wantsum Medical Group Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14490110 . The registered office is 20-22 Wenlock Road, London, N1 7GU.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 8
8
For the period ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Lord Mark Mulvihill
Director
7th April 2025